PapersPMID:26192328
Salvia Miltiorrhiza Root Water-Extract (Danshen) Has No Beneficial Effect on Cardiovascular Risk Factors. A Randomized Double-Blind Cross-Over Trial.
- findings
- 6
- compound
- 1
- endpoints
- 6
- no difference found
- 5
- Study, every finding
- crossover · 4 weeks
- Dose studied, every finding
- 4 capsules of 500 mg granulate three times daily (3 g water-extract daily, equivalent to 15 g root), 28 days
- Population, every finding
- Adults aged 40 to 70 years with hyperlipidemia and hypertension; randomized double-blind placebo-controlled crossover, 4 weeks per period with 4-week washout; study medication taken on top of usual medication in both periods (half the participants on diuretics or beta-blockers)
What moved
How to read these marks →- Increases LDL cholesterol
limited
“When the effect on Danshen was expressed as change from baseline and corrected for the changes observed during placebo treatment, LDL-cholesterol was significantly increased (Table 3) while other lipid fractions were not affected.”
- Interests
- Industry funded
What did not
“Danshen treatment did not affect High Density Lipoprotein (HDL) cholesterol, triglycerides and Apolipoprotein B.”
- Interests
- Industry funded
- Interests
- Industry funded
“Treatment with Danshen did not affect fasting plasma glucose levels (Danshen 5.7±0.1 mmol/l vs placebo 5.8±0.2 mmol/l, p = 0.48) and HbA1c levels (5.8±0.09% and 5.7±0.08%, respectively, p = 0.45).”
- Interests
- Industry funded
- Interests
- Industry funded
“C-reactive protein (CRP) levels were not significantly different after Danshen (2.9±0.7 mg/l) compared to placebo treatment (2.7±0.7 mg/l).”
- Interests
- Industry funded
Study record
- Design
- crossover trial
- Species
- human
- Population
- Subjects aged 40-70 years with hyperlipidemia and hypertension, recruited through newspaper advertisements, tertiary referral center; subject is Danshen, a water-extract of Salvia miltiorrhiza root, versus placebo, 4 weeks each with 4 weeks washout
- Participants
- 20
- Comparator
- placebo
- Duration
- 28 days
- Endpoints measured
- 38